Market Exclusive

Invitae Corporation (NYSE:NVTA) Files An 8-K Results of Operations and Financial Condition

Invitae Corporation (NYSE:NVTA) Files An 8-K Results of Operations and Financial Condition

Item 2.02

Results of Operations and Financial Condition.

On February 13, 2017, Invitae Corporation (the Company) issued a
press release announcing financial results for its fiscal quarter
and year ended December 31, 2016. The full text of the press
release is furnished as Exhibit 99.1 to this report.

The information in Item 2.02 of this Current Report on Form 8-K,
including Exhibit 99.1, shall not be deemed to be filed for
purposes of Section 18 of the Securities Exchange Act of 1934
(the Exchange Act), or otherwise subject to the liability of that
section, and shall not be incorporated by reference into any
registration statement or other document filed under the
Securities Act of 1933 or the Exchange Act, except as shall be
expressly set forth by specific reference in such filing.

Item 9.01

Financial Statements and Exhibits.

(d) Exhibits

Exhibit No.

Description

99.1

Press release issued by Invitae Corporation dated
February 13, 2017.

About Invitae Corporation (NYSE:NVTA)
Invitae Corporation (Invitae) utilizes an integrated portfolio of laboratory processes, software tools and informatics capabilities to process deoxyribonucleic acid (DNA)-containing samples, analyze information about patient-specific genetic variation and generate test reports for clinicians and their patients. The Company’s laboratory is located in San Francisco, California. The Company’s product is an assay of over 600 genes that can be used for multiple indications. The test includes multiple genes associated with hereditary cancer, neurological disorders, cardiovascular disorders and other hereditary conditions. The Company offers panels for over 120 conditions in hereditary cancer, cardiology, neuromuscular, pediatric and rare diseases. The Company offers full gene sequencing and deletion/duplication analysis as a standard for all of its tests. It has developed an offering that enables healthcare professionals to customize a test and receive test results at requisition. Invitae Corporation (NYSE:NVTA) Recent Trading Information
Invitae Corporation (NYSE:NVTA) closed its last trading session up +0.29 at 9.16 with 312,761 shares trading hands.

Exit mobile version